Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
 
Advanced search:
Enter Search Keyword
 
Filter your search by:
Industry
Country
Publish date
Search By Price Range
From:$
    To:$
 
La Merie Publishing
Results 1-10 of 132  1 2 3 >  Last › Sort By :
Title Date Price
TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016: Convergence of technologies opens business opportunities beyond CD19 CARTs
By La Merie Publishing
The report „TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016: Convergence of technologies opens business opportunities beyond CD19 CARTs“ describes and analyzes the status of ...Read More
Aug 2016 $2750.00
TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016: Convergence of technologies opens business opportunities beyond CD19 CARTs
By La Merie Publishing
TCR &  CAR Engineered T-Cell and NK Cell Therapeutics 2016:   Convergence of technologies opens business opportunities  beyond CD19 CARTs   The report „TCR &  ...Read More
Aug 2016 $2750.00
T-Cell Redirecting Bispecific Antibodies 2016: A competitive landscape analysis of stakeholders, technologies, pipelines and deals
By La Merie Publishing
Immunotherapy of cancer with direct or indirect use of T-cells is one of the most exciting fields of cancer research. Direct T-cell therapy implies the ex vivo engineering of autologous or allogeneic ...Read More
May 2016 $2400.00
RORgamma Modulators 2016: A comparative analysis of the landscape of RORgamma antagonists and agonists
By La Merie Publishing
Retinoic acid-related orphan nuclear receptor gamma (RORgamma) is a hot, but „difficult-to-drug“ target. More than 30 companies are active in drug discovery and development. Technology com ...Read More
Feb 2016 $1050.00
Antibody-Drug Conjugates 2016: Perspectives & Opportunities - a Pipeline, Technology, Stakeholder & Business Analysis
By La Merie Publishing
This report describes and analyzes the situation of antibody-drug conjugates as of November 2015 regarding     ADC pipeline,     ADC technologies,     ADC ...Read More
Nov 2015 $2500.00
Competitor Analysis: Interleukin-17/Receptor (IL-17/R) Antagonists
By La Merie Publishing
Competitor Analysis: Interleukin-17/Receptor (IL-17/R) Antagonists The Competitive Intelligence report about Interleukin-17 (IL-17) inhibitors and IL-17 receptor IL-17R) antagonists provides a compet ...Read More
Aug 2015 $170.00
Filgrastim & Pegfilgrastim Biosimilars & Biosuperiors 2015 ? a G-CSF & GM-CSF Competitor Analysis
By La Merie Publishing
The Competitive Intelligence report Filgrastim & Pegfilgrastim Biosimilars & Biosuperiors 2015 – a G-CSF & GM-CSF Competitor Analysis describes product portfolios and R&D pipelin ...Read More
Jul 2015 $460.00
Competitor Analysis: Therapeutic Antibodies 2015 - Biosimilars & Biosuperiors
By La Merie Publishing
Competitor Analysis: Therapeutic Antibodies 2015: Biosimilars & Biosuperiors This Competitive Intelligence Report about Therapeutic Antibodies 2015: Biosimilars & Biosuperiors provides a comp ...Read More
Apr 2015 $1500.00
Engineered TCR and CAR Immunotherapeutics 2015
By La Merie Publishing
The engineered T cell receptor (TCR) for targeting of intracellular targets not druggable by conventional antibody technologies, and specifically targeted engineered T cells are two of the most promis ...Read More
Mar 2015 $2630.00
Competitor Analysis: IDO & TDO Inhibitors-Novel Immune Response Checkpoint Modulators
By La Merie Publishing
The Competitive Intelligence report aboutIDO & TDO Inhibitors - Novel Immune Response Checkpoint Modulators provides a competitor analysis as of March 2015 in the development pipeline of novel inh ...Read More
Mar 2015 $185.00
Results 1-10 of 132  1 2 3 >  Last ›

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z